There is a very good chance that whatever SARS-CoV-2 vaccine (or vaccines) we end up with will only prevent disease, but not infection. What does this mean? Short thread. (1/n)
Antibodies induced by vaccines or viruses can be neutralizing or non-neutralizing. Neutralizing antibodies don’t just bind viral antigens, but inactivate the virus and prevent infection of new cells. (2/n)
This means that the virus cannot replicate, leave the cell (or individual), and infect a new person. (3/n)
Non-neutralizing antibodies don’t inactivate the virus, allowing it to replicate in the cells of the immunized person. However, non-neutralizing antibodies can still engage other elements of the adaptive immune response and prevent disease in the immunized person. (4/n)
It is possible that prospective SARS-CoV-2 vaccines will only induce non-neutralizing antibodies. What does this mean for the community? It means that only the immunized person will be protected from disease, but that person can still act as a carrier... (5/n)
... and potentially infect other, non-immunized people and cause disease in those people. This could cause issues with people who can’t receive vaccines, such as people with immune deficiencies or cancer patients. (6/7)
However, even a vaccine that does not protect from infection but prevents disease in the vaccine recipient will still make a huge positive difference in terms of the pandemic. (end)
• • •
Missing some Tweet in this thread? You can try to
force a refresh
If you have never read one of my articles before, I am begging you to read this one. It describes a strategy for how to end the pandemic and how YOU can help! A thread, also at virology blog. (1/n) virology.ws/2020/08/06/how…
As of today, SARS-CoV-2 has infected 18.7 million people and caused 700,000 deaths worldwide. (2/n)
The most realistic way to quickly curb the spread of the virus would require daily identification and isolation of individuals who are contagious, a process that is hampered by cumbersome sampling and testing methods with slow turnaround times. (3/n)
Hydroxychloroquine (HCQ) Does not Work for Treating COVID-19. THE END.
***Warning! This post may be an emotional trigger for some! I’m just presenting the facts.***
Long thread. (1/n)
Sometime at the beginning of this never-ending year the president announced that HCQ was a “game-changer” for treating COVID-19. While I would be hesitant to embrace any drug as a game-changer without any real evidence, at that time, I did read a couple of studies... (2/n)
...done in Marseille, France, and felt cautiously optimistic about HCQ. When those studies came out, I posted about both of them and will summarize them briefly here. The first study showed that the drug can reduce viral load in a small number of COVID-19 patients. (3/n)
Does a first infection with SARS-CoV-2 make a person immune to a second infection? This question is one of the prevailing issues in the current pandemic. A thread (also at virology blog). (1/n)
The relevant immune response is adaptive immunity, which initiates during a first exposure to a pathogen and protects from re-infection and disease upon a second exposure to the same pathogen. (2/n)
During that first exposure, T helper cells sense the presence of one or more proteins (i.e., antigens) on the surface of the invading pathogen and release a variety of signals that ultimately stimulate B cells to secrete antibodies to those antigens. (3/n)
Remember the polio vaccine that was administered on a sugar cube? As it turns out, that vaccine may prevent against infection with SARS-CoV-2. The vaccine in question is the oral polio vaccine (OPV), a live-attenuated virus vaccine. A thread. (1/n) microbe.tv/twiv/twiv-604/
It is a known fact that there are viruses that are persistently present in the population and that you can always isolate such viruses from healthy children. These viruses replicate “under the radar” and don’t cause disease. (2/n)
A couple of examples include several adenoviruses, rhinoviruses, etc. Back in the polio days when they were conducting clinical trials for OPV, they found that these other viruses were completely wiped out in children who had received OPV. (3/n)
Why do some recovered COVID-19 patients test positive again after testing negative? Do these patients really become “re-infected”? (Spoiler alert: probably not). A thread. (1/n)
The answer to this question has to do with the test that is used to diagnose infection. But before I get to that, I would like to briefly clarify that coronaviruses do not “lay dormant” or “reactivate.” (2/n)
The dormancy phenomenon is kind of unique to viruses like herpesviruses, papillomaviruses and HIV. Coronaviruses don’t do that! They enter a cell, replicate and get out to infect others. (3/n)
TODAY’S UPDATE ON SARS-COV-2 (3/25/20)
Summary of today’s episode of #twiv. The purpose of this episode was to answer YOUR questions! I encourage you to listen to the whole episode yourself! The link is below. (1/n) microbe.tv/twiv/twiv-594/
[The TWiV team is doing daily searches on PubMed, bioRxiv, and medRxiv for a regular and comprehensive review of the COVID-19 and SARS-CoV-2 literature]. (2/n)
What’s the deal with antibody tests? Progress is being made on production of antibody tests. The detection of antibodies in your serum could tell you whether you have been infected with SARS-CoV-2 in the past and whether you are now immune. (3/n)